The Heart Foundation, often in partnership with the Cardiac Society of Australia and New Zealand (CSANZ), Australian Chronic Disease Prevention Alliance (ACDPA) and other aligned organisations, develops high quality, evidence-based clinical guidelines for a range of cardiovascular conditions.
Our guidelines are co-developed with healthcare professionals and consumers to ensure the guidance is relevant and meets the needs of the Australian community.
New Australian clinical guideline for diagnosing and managing acute coronary syndromes (ACS) 2025
Australian guideline and calculator for assessing and managing cardiovascular disease risk.
Clinical information for diagnosis and management of hypertension.
Guidelines for the prevention, detection and management of heart failure in Australia, for health professionals including general practitioners, cardiologists, cardiothoracic surgeons, nurses, pharmacists, and other allied health professionals.
Atrial fibrillation (AF) is the most common recurring arrhythmia faced in clinical practice. It’s estimated that AF is prevalent in two to four per cent of the population in developed nations, such as Australia, and causes substantial morbidity and mortality.
Australian guidelines for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease.